Cargando…

Hinokiflavone Inhibits MDM2 Activity by Targeting the MDM2-MDMX RING Domain

SIMPLE SUMMARY: MDM2 is a ubiquitin E3 ligase, frequently overexpressed in human cancers. A biflavonoid Hinokiflavone was identified by virtual screening to bind the MDM2-MDMX RING domain and inhibit MDM2 E3 ligase activity. Hinokiflavone was shown to downregulate MDM2 and its homolog protein MDMX a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ilic, Viktoria K., Egorova, Olga, Tsang, Ernest, Gatto, Milena, Wen, Yi, Zhao, Yong, Sheng, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138535/ https://www.ncbi.nlm.nih.gov/pubmed/35625571 http://dx.doi.org/10.3390/biom12050643

Ejemplares similares

Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX RING Domains in U2OS Cells
por: Egorova, Olga, et al.
Publicado: (2020)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
por: Mrkvová, Zuzana, et al.
Publicado: (2019)

Regulation of p53: a collaboration between Mdm2 and MdmX
por: Pei, Dongsheng, et al.
Publicado: (2012)

Role of Mdm2 and Mdmx in DNA repair
por: Eischen, Christine M.
Publicado: (2017)

Length matters: C-terminal tails regulate Mdm2–MdmX complexes
por: Poyurovsky, Masha V.
Publicado: (2012)

Controlling the Mdm2-Mdmx-p53 Circuit
por: Waning, David L., et al.
Publicado: (2010)

Targeting RING domains of Mdm2–MdmX E3 complex activates apoptotic arm of the p53 pathway in leukemia/lymphoma cells
por: Wu, W, et al.
Publicado: (2015)

MDM4 (MDMX) and its Transcript Variants
por: Mancini, F, et al.
Publicado: (2009)

A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize
por: Kosztyu, Pavlína, et al.
Publicado: (2019)

p53 Phosphomimetics Preserve Transient Secondary Structure but Reduce Binding to Mdm2 and MdmX
por: Levy, Robin, et al.
Publicado: (2019)

Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells
por: Gao, Chong, et al.
Publicado: (2019)

Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects
por: Kon, Ning, et al.
Publicado: (2018)

Mdmx promotes genomic instability independent of p53 and Mdm2
por: Carrillo, Alexia M., et al.
Publicado: (2014)

Mouse modelling of the MDM2/MDMX−p53 signalling axis
por: Tackmann, Nicole R., et al.
Publicado: (2017)

The MDM2/MDMX/p53 axis in the adaptive stress response
por: Wang, Bing, et al.
Publicado: (2020)

The roles and regulation of MDM2 and MDMX: it is not just about p53
por: Klein, Alyssa M., et al.
Publicado: (2021)

The alternative translated MDMX(p60) isoform regulates MDM2 activity
por: Tournillon, Anne-Sophie, et al.
Publicado: (2015)

The p53/MDM2/MDMX-targeted therapies—a clinical synopsis
por: Jiang, Liren, et al.
Publicado: (2020)

MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling
por: Venkatesh, Divya, et al.
Publicado: (2020)

Ribosomal Proteins RPL37, RPS15 and RPS20 Regulate the Mdm2-p53-MdmX Network
por: Daftuar, Lilyn, et al.
Publicado: (2013)

The fate of murine double minute X (MdmX) is dictated by distinct signaling pathways through murine double minute 2 (Mdm2)
por: Hauck, Paula M., et al.
Publicado: (2017)

Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB
por: Hernández-Monge, Jesús, et al.
Publicado: (2016)

Rigorous Computational and Experimental Investigations on MDM2/MDMX-Targeted Linear and Macrocyclic Peptides
por: Diller, David J., et al.
Publicado: (2019)

Activation of p53 and destabilization of androgen receptor by combinatorial inhibition of MDM2 and MDMX in prostate cancer cells
por: Chopra, Harman, et al.
Publicado: (2017)

Amplification of Mdmx and overexpression of MDM2 contribute to mammary carcinogenesis by substituting for p53 mutations
por: Yu, Qiong, et al.
Publicado: (2014)

Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells
por: Slabáková, Eva, et al.
Publicado: (2015)

Design of stapled peptide-based PROTACs for MDM2/MDMX atypical degradation and tumor suppression
por: Chen, Si, et al.
Publicado: (2022)

A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein
por: Valianatos, Georgios, et al.
Publicado: (2017)

Deconstructing nucleotide binding activity of the Mdm2 RING domain
por: Priest, Christina, et al.
Publicado: (2010)

Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer
por: Swetzig, Wendy M., et al.
Publicado: (2016)

Predicted Functions of MdmX in Fine-Tuning the Response of p53 to DNA Damage
por: Kim, Sohyoung, et al.
Publicado: (2010)

Insight Into the Binding Mechanism of p53/pDIQ-MDMX/MDM2 With the Interaction Entropy Method
por: Li, Mengxin, et al.
Publicado: (2019)

The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells
por: Matijasevic, Z, et al.
Publicado: (2016)

Stress-Induced Alternative Splice Forms of MDM2 and MDMX Modulate the p53-Pathway in Distinct Ways
por: Jacob, Aishwarya G., et al.
Publicado: (2014)

Cisplatin causes cell death via TAB1 regulation of p53/MDM2/MDMX circuitry
por: Zhu, Yan, et al.
Publicado: (2013)

New insight into the role of MDMX in MDM2-mediated p53 degradation and anti-cancer drug development
por: Yang, Jing, et al.
Publicado: (2021)

Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
por: Liu, Tao, et al.
Publicado: (2015)

Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen
por: Qin, Jiang-Jiang, et al.
Publicado: (2017)

Anatomy of Mdm2 and Mdm4 in evolution
por: Tan, Ban Xiong, et al.
Publicado: (2017)

Diaryl- and triaryl-pyrrole derivatives: inhibitors of the MDM2–p53 and MDMX–p53 protein–protein interactions
por: Blackburn, Tim J., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nv7biaocd8nsejckr5ad9lm0i3